April 18, 2025

CAP Issues New and Updated Cancer Protocols

New protocols for endocrine tumors and updated existing protocols for breast cancer diagnoses are now available from the College of American Pathologists (CAP).

The ASCO Post

April 18, 2025

Activity of ROS1 TKI in NSCLC

A pooled analysis of the phase II TRUST-I and TRUST-II trials reported efficacy and safety findings on the use of the oral next-generation ROS1 tyrosine kinase inhibitor (TKI) taletrectinib in ROS1-po...

The ASCO Post

April 18, 2025

Metabolic Syndrome May Increase Risk of Cancer Recurrence, Subsequent Mortality Among Breast Cancer Survivors

Can metabolic syndrome raise the risk of breast cancer recurrence and subsequent mortality among breast cancer survivors? Researchers will present data on this topic at the upcoming European Congress ...

The ASCO Post

April 17, 2025

In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers

Four noteworthy studies from the 2025 ASCO Gastrointestinal Cancers Symposium, each shedding new light on emerging therapeutic approaches for patients with advanced gastric, hepatocellular, and colore...

The ASCO Post

April 17, 2025

How Does Medicaid Expansion Affect Access to Care in Patients With NSCLC?

Medicaid expansion was associated with a 2.8% increase in lung cancer surgeries performed and a 2.1% increase in surgeries completed within 90 days of diagnosis at high-volume hospitals.

The ASCO Post

April 17, 2025

Advanced Esophageal Cancer: NOTCH1 Mutation and Efficacy of Tislelizumab

“Although multiple agents targeting PD-1 have been approved as second-line treatment for esophageal squamous cell carcinoma, only a fraction of patients derive long-term survival. Hence, reliable pred...

The ASCO Post

April 16, 2025

Parasitic Infection and Its Treatment Linked to Cancer-Related Gene Activity in the Cervix

Research presented at ESCMID Global 2025 revealed that Schistosoma haematobium, a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with...

The ASCO Post

April 16, 2025

Novel Drug/Device Combination May Improve Outcomes in Metastatic Uveal Melanoma

Researchers have examined whether percutaneous hepatic perfusion using a melphalan hepatic delivery system may be an effective treatment option in patients with unresectable uveal melanoma that has me...

The ASCO Post

April 16, 2025

Can ctDNA Monitoring Help to Predict Melanoma Recurrence?

A new report shows how droplet digital polymerase chain reaction assays focusing on monitoring the most common mutations in the genetic code in melanoma cells—BRAF V600E and BRAF V600K—may help to pre...

The ASCO Post